Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel-based antiplatelet therapy vs warfarin for secondary prevention of antiphospholipid syndrome-related stroke
KCT0008900Phase 4Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, warfarin in antiphospholipid syndrome (APS), ischemic stroke, sponsored by Seoul National University Hospital. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
clopidogrelwarfarin
03
Conditions
antiphospholipid syndrome (APS)ischemic stroke
Beyond the preview
Go deeper on KCT0008900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008900.